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Abstract: Homocysteine (Hcy) is a critical indicator of cardiovascular disease. High levels of Hcy have now been recognised 
as a risk factor for the development of a wide range of diseases. Hyperhomocysteinemia (Hhcy) can be induced by methionine or 
Hcy supplementation. On the other hand, Glutathione (GSH) is a major antioxidant in the body and also an important compound 
for oxidative defence. It is composed of 3 amino acids: cysteine, glutamate, and glycine. Interestingly, methionine is also a 
crucial compound in GSH synthesis. This study aims to assess the impact of 1% L-methionine feeding (10 or 30 weeks) on the 
body weight and serum Hcy and GSH levels of young adult (16 weeks) and middle-aged (36 weeks) Wistar rats of both sexes. 
Serum was analysed for Hcy and reduced GSH levels by liquid chromatography mass spectrometry (LCMS) in response to 1% 
L-methionine feeding. One percent L-methionine feeding decreased body weight in all conditions investigated, although this 
only reached significance in males after 10 weeks supplementation and females after 30 weeks supplementation. It also induced 
a significant increase in the serum Hcy levels of male Wistar rats, whilst having no significant effect on Hcy serum levels in 
female rats. Finally, we also observed a small increase in serum GSH levels in female Wistar rats but no change in serum GSH 
levels in the males. These results suggest that methionine feeding affects body weight homeostasis and alters by products of 
methionine catabolism. 
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1. Introduction 
Elevated concentrations of serum homocysteine (Hcy) have 
recently been shown to be a high risk factor for cardiovascular 
diseases [1]. Normally Hcy is biosynthesised during 
methionine metabolism [2-3]. The harmful effect of a high 
methionine diet is due to the conversion of methionine into 
Hcy, which in turn induces endothelial and oxidative stress 
[4-5]. 
The correlation between Hcy and cardiovascular diseases 
has been known since the 1960s [6]. A disturbance in the 
Hcy metabolic pathway causes Hcy accumulation leading to 
Hyperhomocysteinemia (Hhcy) [7-9]. In addition, common 
causes for Hhcy are: renal disease [10], insufficiency of 
vitamins contributing to Hcy metabolism [11], excess amount 
of dietary methionine [12-13] and also deficit of enzymes 
involved in Hcy metabolism [3]. It has been reported that in 
atherosclerotic patients with high levels of cholesterol, there 
was a considerable elevation in plasma Hcy concentrations 
[14]. 
There is abundant evidence indicating that high levels of 
Hcy induce damage to the heart and blood vessels. Boushey 
et al. [15] found that an elevation of 5 µmol/L in total serum 
Hcy (tHcy) concentration increases the odds of developing 
coronary artery disease (CAD) by 1.6 in males and 1.8 in 
22 Shatha Ahmad Demerchi et al.:  Effect of L-Methionine Feeding on Serum Homocysteine and Glutathione  
Levels in Male and Female Wistar Rats 
females. They further state that 10% of the population’s risk 
of CAD is attributable to Hhcy [15]. Also a lack of one or 
more of the vitamins (B6, B12, folic acid) may disturb 
methionine metabolism, resulting in Hhcy [16]. Normally, 
Hcy is converted into two critically important compounds: 
S-adenosyl methionine (SAM) and glutathione (GSH). This 
pathway is vital to maintain low levels of Hcy [17]. Also 
three specific vitamins B6, B12 and folate as well as zinc and 
tri methyl glycine (TMG) are involved in the conversion of 
Hcy to SAM [18]. Vitamins B6 and B12 and zinc also 
contribute in the conversion of Hcy to GSH [19]. The 
concentration of Hcy in the blood increases when the body 
does not efficiently convert Hcy into SAM and GSH [3, 20- 
21]. It has been shown that, in the elderly, non-fasting tHcy 
levels are increased and contribute to the increasing rates of 
cardiovascular disease mortality [22]. 
GSH, a sulfhydryl (SH)-containing tripeptide, is composed 
of three amino acids (glutamate, glycine and cysteine) [23-24] 
and is found in all mammalian cells [25]. In particular, it acts 
as an antioxidant, detoxifying agent and a free radical 
scavenger. Our working hypothesis is that methionine 
feeding affects body weight and causes changes in serum 
Hcy and serum GSH levels. To test this hypothesis, body 
weight and serum Hcy and serum GSH concentrations of 
young adult (16 weeks) and middle-aged (36 weeks) (female 
and male) Wistar rats were measured in control and those fed 
with 1% L-methionine. 
2. Materials and Methods 
2.1. Chemicals 
Standards, Hcy, GSH, and dithiothreitol (DTT) were from 
Sigma-Aldrich (Sydney, NSW, Australia), formic acid was 
from Fluka, LC-MS grade acetonitrile and H2O were from 
Burdick and Jackson. 
2.2. Experimental Animals 
Young post-weaned Wistar rats (6 weeks old) (body 
weight, 130 - 190 gm) (n = 48) of both sexes were divided 
into 2 sets of four groups (n=6 in each group) according to 
sex and diet. The control groups routinely received standard 
rat chow and water ad libitum while the test groups received 
standard rat chow and water supplemented with 1% 
L-methionine [26] for 10 weeks for the first set and 30 weeks 
[27-28] for the second set of animals (rats fed for 10 weeks 
are called young adult and rats fed for 30 weeks are called 
middle-aged). Regular checks were made of the rats’ weight, 
general health and well-being. At the end of this time the rats 
were sacrificed by stunning and cervical dislocation. The rats 
were then decapitated and trunk blood samples collected into 
Eppendorf tubes according to guidelines from the National 
Centre for the Replacement, Refinement and Reduction of 
animals in Research (NC3R
S
). Blood specimens were left to 
coagulate at room temperature and then centrifuged for 10 
minutes at 4000 rpm using a tabletop centrifuge (Sigma, 
Mode No. 1-15, Germany). The serum was then removed and 
transferred into clean Eppendorf tubes and stored frozen at – 
80˚C until used. This study was approved by the Animal 
Ethics committee of the University of New England and 
followed international guidelines. 
2.3. Measurement of Serum Hcy with Liquid 
Chromatography Gas Spectrometry 
The samples were prepared according to Shimadzu 
Application News No. C92. The serum samples were thawed. 
100 µl of serum was put into a labelled Eppendorf tube and 
20 µl (1mg/ml) DTT added. The solution was vortexed on 
high and allowed to stand at room temperature for 10 minutes 
(2x). After that 300 µl of 0.2% (1:500 v/v) HCOOH-CH3CN 
(formic acid/acetonitrile) was added and the solution was 
vortexed on high. Then the solution was centrifuged (Sigma, 
Mode No. 1-15, Germany) at 12000 rpm (9659.52 g) for 2 
minutes and 150µl of supernatant transferred to a labelled 
vial. 
Serum Hcy concentrations were quantified in young adult 
rats (n=24) and middle-aged rats (n=24) of both sexes using 
high-performance liquid chromatography-triple quadrupole 
mass spectrometer (Shimadzu, LCMS-8050, Japan). Both 
control of instrumentation and data analysis were performed 
using standard Shimadzu software (Lab Solutions v.5.8). The 
MS parameters were set at – m/z 136.00>90.10 and 
136.00>56.10 for Hcy. Standard Hcy was made up into serial 
dilutions ranging from 62.5-2000 ng/ml in LC-MS grade 
water, analysed and plotted using Shimadzu Lab Solutions. 
2.4. Measurement of Serum GSH with Liquid 
Chromatography Mass Spectroscopy 
The serum GSH concentrations were measured on the 
same samples as the Hcy. The MS parameters were modified 
to m/z 308.00>179.10 in order to detect GSH. For 
quantification, a standard curve of GSH solutions ranging 
from 62.5-2000 ng/ml was determined. 
2.5. Data Analysis 
Statistical analyses were expressed as Mean (SD). Student 
T tests were used for significance of difference between 
control and treated groups. Statistical significance was 
considered at p<0.05. 
3. Results 
3.1. Determination of Body Weight 
Table 1. Effect of L-methionine feeding on growth in (young adult) male and 
female Wistar rats. Data are means ± SD body weight (n=6). *p<0.05 vs. 
control. 
Sex 
Body weight (g/10 weeks) Body weight (g/10 weeks) 
Control 1% Methionine 
Male 350.46±26.75 314.45±28.37* 
Female 154.90±20.30 141.98±14.15 
The weight gain from young adult male Wistar rats fed 1% 
L-methionine was found to be significantly less at 314.45 
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(28.37) grams mean (SD) (p<0.05) after 10 weeks than the 
control group at 350.45 (26.75) grams mean (SD). Although 
the same trend was observed for the young adult female 
Wistar rats, the difference did not reach significance (see 
Table 1). 
For the middle-aged rats, we observed a lower weight gain 
of 680.03 (64.34) grams mean (SD) in males fed 1% 
L-methionine during the 30 weeks when compared to 
controls which increased to 752.89 (62.08) grams mean (SD), 
however this change was not significant. On the other hand, 
there was a highly significant lower weight gain for the 
female rats with 257.88 (50.80) grams, mean (SD) (p<0.001) 
when compared to controls with 376.14 (15.50) grams (see 
Table 2). 
3.2. Measurement of Serum Hcy and Serum GSH 
Young adult and middle-aged data were merged together 
because there were no differences between the two 
population values. 
Serum Hcy and GSH levels for the female rats increased in 
1% L-methionine rats to 7.819 (2.91) µM [mean (SD)] and 
32.303 (10.83) µM when compared to control at 4.87 (1.497) 
µM and 21.38 (8.88) µM respectively, although they were 
not statistically significant (Figure 1). 
Serum Hcy levels of male Wistar rats were significantly 
higher in 1% L-methionine rats at 11.32 (7.05) µM [mean 
(SD)] p<0.05 when compared to control at 5.33 (1.26) µM. 
Table 2. Effect of L-methionine feeding on growth in (middle-aged adult) 
male and female Wistar rats. Data are means ± SD body weight (n=6). 
*p<0.001 vs. control. 
Sex 
Body weight (g/30 weeks) Body weight (g/30 weeks) 
Control 1% Methionine 
Male 752.89±62.08 680.03±64.34 
Female 376.14±15.50 257.88±50.80* 
Serum GSH levels were only slightly lower in 1% L- methionine rats at 
24.89 (7.56) µM when compared to control at 27.53 (7.84) µM (Figure 2). 
4. Discussion 
Our results have shown that 1% L-methionine 
supplementation in the drinking water caused a significant 
decrease in the body weight of young adult male Wistar rats 
compared to control and a similar trend in the body weight of 
young adult female Wistar rats in comparison to control 
(Table 1). Also, there was a trend towards a reduction in the 
body weight in the middle-aged male rats compared to 
control and a significant reduction in the middle-aged female 
rats compared to control (Table 2). This could be correlated 
with an increase in the rate of methionine metabolism due to 
excessive dietary methionine. It has been found that the 
amount of methionine required from the diet is less than 1% 
and excess amounts of methionine can be toxic [29]. Another 
study reported that excessive levels of methionine may 
convert into S-methyl-L-cysteine which is a toxic compound 
and leads to growth reduction [30]. These findings were 
similar to that obtained by Herrmann et al. [31] who found 
that supplementation with 2.4% methionine, 1% Hcy and 2% 
Hcy in female Wistar rats reduced body weight significantly. 
In addition, findings from other studies indicated that 1.6 
gm/kg L-methionine feeding led to significantly slower 
growth rate of experimental rats compared to control [27]. 
However, El Aty et al. [32] found a significant increase in 
rats’ body weights at tested concentrations (1%, 2% and 4%) 
of DL-methionine and also another study by Hegedus et al. 
[33] indicated that body weight increases at high dietary 
protein diet. The disagreement between the findings may 
possibly be due to various factors. For example, animal strain, 
feeding period, isomeric forms of methionine, examined 
concentration of methionine and mode of treatment, injection 
(subcutaneous or intraperitoneal (IP)) or supplementation. 
This is the first study to investigate the effects of 
methionine supplementation in female rats. Our results 
indicated that the serum Hcy values of control groups are in 
agreement with those reported by Durand et al. [12] and 
Meng et al. for the male rat [34]. Serum Hcy values in the 
methionine groups are in agreement with that found by Meng 
et al. for the male rat [34]. We also report increased serum 
concentrations of Hcy in 1% L-methionine fed rats compared 
to control, which while not statistically significant for young 
adult and middle-aged (female) rats (Figure 1) became 
significant in young adult and middle-aged (male) rats 
(Figure 2). Dietary methionine plays an important role in the 
generation of Hcy through the demethylation pathway. This 
is a recognised method for inducing Hhcy [12]. 
 
Figure 1. Serum Hcy concentration (µM) versus serum GSH concentration 
(µM) in female rats fed with 1% L-methionine in comparison to control. Data 
shown are the means (SD). 
Our results are in agreement with de Rezende & D’Almeida 
[35] who found that 0.5% methionine supplementation in 
water increased plasma homocysteine concentration after 2 
and 6 months and also that 1% methionine supplementation in 
water, increased plasma homocysteine concentration after 2, 4 
and 6 months in male C57BL/6 mice. Results from other 
studies have also indicated that methionine or Hcy 
supplementation significantly raised plasma total Hcy levels, 
which accelerates plaque growth and boosts plaque fibrosis in 
apoE-/- mice [36] and also influences myocardial brain 
natriuretic peptide (BNP) concentrations in rats [31]. A study 
by Nygård et al. [37] revealed that human plasma Hcy levels 
are higher in men than in women and increases with age. Our 
results also indicated that males have higher serum Hcy levels 
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than females, although the difference was not significant in the 
rat. We did not observe any differences in Hcy levels with age. 
The mechanism of sex differences in Hcy concentrations may 
be due to alterations in rates of Hcy remethylation [38]. A 
small increase in serum GSH concentrations in 1% 
L-methionine fed rats of young adult and middle-aged female 
rats, although they were not statistically significant (Figure 1). 
This finding suggested that methionine loading improves GSH 
synthesis, which is in agreement with Bianchi et al. [39] who 
found that in human cirrhosis methionine flux is reduced 
through the transmethylation/transsulfuration pathway, which 
in turn reduces GSH synthesis. Mosharov et al. [40] who 
reported that Hcy dependent transsulfuration pathway is vital 
in sustaining the intracellular GSH pool. In males, there were 
no changes in serum GSH concentrations in 1% L-methionine 
fed rats of young adult and middle-aged male rats compared to 
controls (Figure 2). Given the significant increase in serum 
Hcy concentrations, changes in redox balance and impaired 
antioxidant defence mechanisms may be involved in this group. 
Indeed, Vyas et al. [41] found that GSH concentrations can 
significantly decrease during oxidative stress (increased free 
radical generation) in osteoarthritis patients. Moreover, another 
finding by Pastore et al. [42] demonstrated that in patients with 
non-alcoholic fatty liver diseases an increase in oxidative stress 
can be associated with rising plasma Hcy and cysteine levels 
and depletion of GSH levels. Changes in GSH levels can be 
critical in many cases such as inherited or acquired defects in 
the transporters, enzymes, transcription factors that are 
essential in its homeostasis, signalling molecules, or exposure 
to reactive chemicals or metabolic intermediates [43]. 
 
Figure 2. Serum Hcy concentration (µM) versus serum GSH concentration 
(µM) in male Wistar rats fed with 1% L-methionine in comparison to control. 
Data shown are the means (SD). 
5. Conclusion 
The results presented here show that L-methionine 
supplementation affects methionine-homocysteine 
metabolism cycle resulting in increased serum Hcy and 
serum GSH levels. Male rats have higher serum Hcy levels 
than females. The positive interactions between serum Hcy 
and serum GSH concentrations propose a possible common or 
analogous controlling mechanism in females. 
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